United Therapeutics | UTHR - Ebitda

Stock Price
568.58
Daily Change
-7.21 -1.25%
Monthly
-2.06%
Yearly
86.21%
Q2 Forecast
553.25

United Therapeutics reported $379.5M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Amarin USD 12.54M 28.57M Jun/2025
Ardelyx USD 6.02M 447K Dec/2025
Baxter International USD -447M 873M Dec/2025
Bayer EUR 4.45B 2.49B Mar/2026
BioCryst Pharmaceuticals USD 51.7M 30.14M Sep/2025
Biogen USD 649.7M 76.5M Mar/2026
BioMarin Pharmaceutical USD 146.05M 170.22M Mar/2026
Esperion Therapeutics USD -9.93M 24.99M Sep/2025
Gilead Sciences USD 3.02B 1.01B Dec/2025
GlaxoSmithKline GBP 2.77B 1.65B Mar/2026
Halozyme Therapeutics USD 21.9M 226.34M Dec/2025
Insmed USD -148.3M 165.88M Mar/2026
Ionis Pharmaceuticals USD -200.02M 42.89M Dec/2025
J&J USD 7.19B 2.32B Dec/2025
Lexicon Pharmaceuticals USD -12.04M 15.95M Sep/2025
Moderna USD -790M 582M Dec/2025
Omeros USD -47.96M 7.39M Sep/2023
Pfizer USD 5.99B 5.23B Mar/2026
PTC Therapeutics USD -70.99M 91.62M Dec/2025
Regeneron Pharmaceuticals USD 1.2B 718.4M Dec/2025
Sarepta Therapeutics USD -252.2M 84.16M Dec/2025
Teva Pharmaceutical Industries USD 1.06B 582M Mar/2026
United Therapeutics USD 379.5M 83.4M Dec/2025
Vertex Pharmaceuticals USD 1.19B 195.3M Mar/2026